Patents by Inventor Boaz Musafia

Boaz Musafia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Artificial chemical entity comprising a DNA oligonucleotide aptamer that selectively binds MUC1 antigen
    Patent number: 11299740
    Abstract: Disclosed are artificial chemical entities, pharmaceutical compositions comprising such chemical entities and methods using the chemical entities. In some embodiments, the artificial chemical entity comprises a biomarker-bonding portion that selectively binds to a specified biomarker and an immune-response trigger that under in vivo conditions leads to positioning of an antibody Fc region in proximity of the biomarker to which the biomarker-bonding portion is bound.
    Type: Grant
    Filed: January 29, 2018
    Date of Patent: April 12, 2022
    Inventors: Ofer Nussbaum, Boaz Musafia
  • POWER PACK AND POWER PACK CIRCUITRY
    Publication number: 20210020998
    Abstract: A multi-level power cell pack switching circuitry having a plurality of first level cell circuits, and additional plurality of cell circuits of consecutively progressing levels, with switching and control configured to facilitate dynamically changing serial and/or parallel connections between cells and cell circuits.
    Type: Application
    Filed: March 17, 2019
    Publication date: January 21, 2021
    Applicant: EVCHIP ENERGY LTD.
    Inventors: Boaz MUSAFIA, Alon MEDINA
  • CHEMICAL ENTITIES SUITABLE FOR THERAPY
    Publication number: 20190352642
    Abstract: Disclosed are artificial chemical entities, pharmaceutical compositions comprising such chemical entities and methods using the chemical entities. In some embodiments, the artificial chemical entity comprises a biomarker-bonding portion that selectively binds to a specified biomarker and an immune-response trigger that under in vivo conditions leads to positioning of an antibody Fc region in proximity of the biomarker to which the biomarker-binding portion is bound.
    Type: Application
    Filed: January 29, 2018
    Publication date: November 21, 2019
    Inventors: Ofer NUSSBAUM, Boaz MUSAFIA
  • Compositions and methods for the treatment of hypertension
    Publication number: 20050272808
    Abstract: The present invention relates to use of 1,7-dioxaspiro[5.5]undecane and derivatives thereof for the preparation of a medicament for the treatment or prevention of hypertension. The invention also provides a method for treatment or prevention of hypertension using a medicament comprising 1,7-dioxaspiro[5.5]undecane or a derivative thereof as an active ingredient, such that the hypertension is treated or prevented, as the case may be.
    Type: Application
    Filed: May 11, 2005
    Publication date: December 8, 2005
    Inventors: Nadav Zamir, Boaz Musafia